Intelligent Historical Balance Sheet

INBS Stock

USD 1.51 0.05 3.21%

Trend analysis of Intelligent Bio Solutions balance sheet accounts such as Other Current Liabilities of 1.2 M or Total Current Liabilities of 4.6 M provides information on Intelligent Bio's total assets, liabilities, and equity, which is the actual value of Intelligent Bio Solutions to its prevalent stockholders. By breaking down trends over time using Intelligent Bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Intelligent Bio Solutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Intelligent Bio Solutions is a good buy for the upcoming year.

Intelligent Bio Inventory

507,419

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About Intelligent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Intelligent Bio Solutions at a specified time, usually calculated after every quarter, six months, or one year. Intelligent Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Intelligent Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Intelligent currently owns. An asset can also be divided into two categories, current and non-current.

Intelligent Bio Balance Sheet Chart

At this time, Intelligent Bio's Net Invested Capital is comparatively stable compared to the past year.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Intelligent Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Intelligent Bio Solutions books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Intelligent Bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Intelligent Bio Solutions are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Intelligent Bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Intelligent Bio Solutions current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intelligent Bio Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

At this time, Intelligent Bio's Net Invested Capital is comparatively stable compared to the past year.

	2023	2024	2025 (projected)
Short and Long Term Debt Total	871.4K	784.3K	745.1K
Total Assets	13.8M	15.8M	8.9M

Short Long Term Debt Total Total Assets

Intelligent Bio balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Receivables	Common Stock Shares Outstanding	Inventory	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Invested Capital	Short Long Term Debt
Total Assets		-0.82	-0.4	-0.86	0.97	-0.94	-0.83	0.77	0.95	0.95	-0.7	0.49	0.85	-0.4	0.96	-0.87	-0.15	0.89	0.47	-0.88	0.93	0.7	-0.83	0.77	0.95	-0.93
Short Long Term Debt Total	-0.82		0.16	0.76	-0.88	0.85	0.8	-0.56	-0.75	-0.75	0.96	-0.41	-0.93	0.55	-0.72	0.98	0.52	-0.72	-0.52	0.65	-0.74	-0.77	0.67	-0.51	-0.93	0.93
Other Current Liab	-0.4	0.16		0.44	-0.43	0.25	0.59	-0.35	-0.29	-0.29	0.24	0.41	-0.44	0.61	-0.38	0.14	-0.26	-0.25	-0.39	0.15	-0.31	-0.3	0.36	-0.24	-0.39	0.43
Total Current Liabilities	-0.86	0.76	0.44		-0.9	0.9	0.64	-0.63	-0.88	-0.88	0.63	-0.51	-0.76	0.61	-0.89	0.81	0.4	-0.88	-0.49	0.84	-0.76	-0.55	0.56	-0.47	-0.89	0.82
Total Stockholder Equity	0.97	-0.88	-0.43	-0.9		-0.95	-0.87	0.74	0.91	0.91	-0.78	0.45	0.93	-0.52	0.93	-0.9	-0.2	0.87	0.49	-0.85	0.91	0.69	-0.84	0.74	0.99	-0.96
Net Debt	-0.94	0.85	0.25	0.9	-0.95		0.72	-0.68	-0.98	-0.98	0.7	-0.58	-0.81	0.4	-0.97	0.9	0.28	-0.96	-0.58	0.92	-0.92	-0.53	0.76	-0.7	-0.94	0.9
Retained Earnings	-0.83	0.8	0.59	0.64	-0.87	0.72		-0.64	-0.66	-0.66	0.83	-0.05	-0.95	0.56	-0.7	0.77	0.03	-0.6	-0.49	0.53	-0.77	-0.76	0.85	-0.69	-0.88	0.92
Accounts Payable	0.77	-0.56	-0.35	-0.63	0.74	-0.68	-0.64		0.67	0.67	-0.4	0.5	0.61	-0.03	0.72	-0.66	0.12	0.74	0.24	-0.78	0.78	0.59	-0.68	0.67	0.74	-0.74
Cash	0.95	-0.75	-0.29	-0.88	0.91	-0.98	-0.66	0.67		1.0	-0.58	0.58	0.73	-0.35	0.99	-0.81	-0.17	0.96	0.54	-0.93	0.91	0.48	-0.75	0.72	0.89	-0.83
Cash And Short Term Investments	0.95	-0.75	-0.29	-0.88	0.91	-0.98	-0.66	0.67	1.0		-0.58	0.58	0.73	-0.35	0.99	-0.81	-0.17	0.96	0.54	-0.93	0.91	0.48	-0.75	0.72	0.89	-0.83
Non Current Liabilities Total	-0.7	0.96	0.24	0.63	-0.78	0.7	0.83	-0.4	-0.58	-0.58		-0.15	-0.93	0.64	-0.57	0.89	0.51	-0.54	-0.54	0.43	-0.61	-0.76	0.62	-0.41	-0.84	0.87
Other Current Assets	0.49	-0.41	0.41	-0.51	0.45	-0.58	-0.05	0.5	0.58	0.58	-0.15		0.23	0.17	0.54	-0.52	-0.35	0.59	-0.19	-0.76	0.46	0.3	-0.23	0.33	0.44	-0.32
Other Stockholder Equity	0.85	-0.93	-0.44	-0.76	0.93	-0.81	-0.95	0.61	0.73	0.73	-0.93	0.23		-0.65	0.75	-0.89	-0.28	0.67	0.49	-0.61	0.77	0.79	-0.79	0.62	0.95	-0.95
Total Liab	-0.4	0.55	0.61	0.61	-0.52	0.4	0.56	-0.03	-0.35	-0.35	0.64	0.17	-0.65		-0.36	0.44	0.46	-0.25	-0.42	0.13	-0.19	-0.47	0.18	0.04	-0.53	0.51
Total Current Assets	0.96	-0.72	-0.38	-0.89	0.93	-0.97	-0.7	0.72	0.99	0.99	-0.57	0.54	0.75	-0.36		-0.79	-0.1	0.96	0.53	-0.93	0.93	0.5	-0.78	0.76	0.9	-0.85
Short Term Debt	-0.87	0.98	0.14	0.81	-0.9	0.9	0.77	-0.66	-0.81	-0.81	0.89	-0.52	-0.89	0.44	-0.79		0.49	-0.82	-0.53	0.76	-0.81	-0.74	0.69	-0.57	-0.94	0.94
Common Stock	-0.15	0.52	-0.26	0.4	-0.2	0.28	0.03	0.12	-0.17	-0.17	0.51	-0.35	-0.28	0.46	-0.1	0.49		-0.18	-0.11	0.14	0.02	-0.41	-0.21	0.34	-0.29	0.25
Net Receivables	0.89	-0.72	-0.25	-0.88	0.87	-0.96	-0.6	0.74	0.96	0.96	-0.54	0.59	0.67	-0.25	0.96	-0.82	-0.18		0.6	-0.95	0.92	0.4	-0.72	0.7	0.86	-0.82
Common Stock Shares Outstanding	0.47	-0.52	-0.39	-0.49	0.49	-0.58	-0.49	0.24	0.54	0.54	-0.54	-0.19	0.49	-0.42	0.53	-0.53	-0.11	0.6		-0.34	0.56	0.07	-0.46	0.33	0.52	-0.59
Inventory	-0.88	0.65	0.15	0.84	-0.85	0.92	0.53	-0.78	-0.93	-0.93	0.43	-0.76	-0.61	0.13	-0.93	0.76	0.14	-0.95	-0.34		-0.89	-0.43	0.69	-0.72	-0.82	0.75
Net Tangible Assets	0.93	-0.74	-0.31	-0.76	0.91	-0.92	-0.77	0.78	0.91	0.91	-0.61	0.46	0.77	-0.19	0.93	-0.81	0.02	0.92	0.56	-0.89		0.49	-0.93	0.9	0.89	-0.89
Non Current Assets Total	0.7	-0.77	-0.3	-0.55	0.69	-0.53	-0.76	0.59	0.48	0.48	-0.76	0.3	0.79	-0.47	0.5	-0.74	-0.41	0.4	0.07	-0.43	0.49		-0.49	0.35	0.74	-0.75
Non Currrent Assets Other	-0.83	0.67	0.36	0.56	-0.84	0.76	0.85	-0.68	-0.75	-0.75	0.62	-0.23	-0.79	0.18	-0.78	0.69	-0.21	-0.72	-0.46	0.69	-0.93	-0.49		-0.96	-0.81	0.84
Other Assets	0.77	-0.51	-0.24	-0.47	0.74	-0.7	-0.69	0.67	0.72	0.72	-0.41	0.33	0.62	0.04	0.76	-0.57	0.34	0.7	0.33	-0.72	0.9	0.35	-0.96		0.69	-0.7
Net Invested Capital	0.95	-0.93	-0.39	-0.89	0.99	-0.94	-0.88	0.74	0.89	0.89	-0.84	0.44	0.95	-0.53	0.9	-0.94	-0.29	0.86	0.52	-0.82	0.89	0.74	-0.81	0.69		-0.98
Short Long Term Debt	-0.93	0.93	0.43	0.82	-0.96	0.9	0.92	-0.74	-0.83	-0.83	0.87	-0.32	-0.95	0.51	-0.85	0.94	0.25	-0.82	-0.59	0.75	-0.89	-0.75	0.84	-0.7	-0.98

Click cells to compare fundamentals

Intelligent Bio Account Relationship Matchups

Intelligent Bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	20.4M	12.4M	10.4M	13.8M	15.8M	8.9M
Short Long Term Debt Total	5.1M	5.1M	1.3M	871.4K	784.3K	745.1K
Other Current Liab	2.3M	1.1M	1.5M	1.2M	1.1M	1.2M
Total Current Liabilities	3.7M	4.7M	5.9M	5.5M	4.9M	4.6M
Total Stockholder Equity	13.6M	6.6M	3.8M	8.3M	9.6M	10.1M
Net Debt	(12.6M)	(8.2M)	(201.6K)	(5.4M)	(4.9M)	(4.6M)
Retained Earnings	(24.3M)	(31.2M)	(41.8M)	(52.0M)	(46.8M)	(44.4M)
Accounts Payable	1.4M	715.9K	1.2M	602.3K	692.7K	792.1K
Cash	12.6M	8.2M	1.5M	6.3M	7.2M	4.1M
Cash And Short Term Investments	12.6M	8.2M	1.5M	6.3M	7.2M	4.1M
Liabilities And Stockholders Equity	20.4M	12.4M	10.4M	13.8M	15.8M	8.9M
Non Current Liabilities Total	3.2M	1.1M	783.9K	144.9K	130.4K	123.9K
Other Current Assets	2.4M	163.1K	512.2K	474.3K	545.4K	586.1K
Other Stockholder Equity	38.4M	38.4M	46.2M	61.0M	70.1M	73.6M
Total Liab	6.9M	5.8M	6.7M	5.6M	5.0M	5.1M
Total Current Assets	16.4M	10.9M	3.9M	8.5M	9.8M	6.5M
Accumulated Other Comprehensive Income	(661.3K)	(788.1K)	(575.5K)	(712.6K)	(641.4K)	(609.3K)
Short Term Debt	5.1M	137.8K	800.1K	1.1M	958.5K	910.5K
Common Stock	142.3K	148.9K	23.3K	34.6K	31.1K	29.5K
Net Receivables	3.2M	2.5M	833.2K	978.3K	1.1M	1.2M
Common Stock Shares Outstanding	867.9K	14.7M	2.0M	3.2M	3.7M	3.5M
Inventory	(3.2M)	0.0	979.9K	777.5K	699.8K	507.4K
Net Tangible Assets	(5.2M)	15.0M	6.6M	(1.5M)	(1.7M)	(1.8M)
Non Current Assets Total	4.0M	1.5M	6.5M	5.2M	6.0M	3.5M
Net Invested Capital	15.0M	6.6M	4.6M	8.8M	10.2M	10.7M
Capital Stock	148.8K	148.9K	23.3K	34.6K	31.1K	29.5K
Net Working Capital	14.5M	6.2M	(2.0M)	3.1M	3.5M	2.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Intelligent Historical Balance Sheet

Intelligent Bio Inventory

507,419

About Intelligent Balance Sheet Analysis

Intelligent Bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Intelligent Bio balance sheet Correlations

Intelligent Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Intelligent Bio balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Intelligent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Net Invested Capital	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Short Term Debt	+ 0.98	Short Long Term Debt Total
Total Stockholder Equity	+ 0.97	Total Assets

Short Long Term Debt	- 0.98	Net Invested Capital
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Total Current Assets	- 0.97	Net Debt
Other Assets	- 0.96	Non Currrent Assets Other
Net Receivables	- 0.96	Net Debt